Activity of recombinant human interleukin-21 (rIL-21) in patients (pts) with stage IV malignant melanoma (MM) without prior treatment: clinical data from a phase IIa study

I. D. Davis, B. Brady, R. Kefford, M. J. Millward, B. K. Skrumsager, U. Mouritzen, P. E. Kristjansen, G. A. McArthur

Research output: Contribution to journal › Meeting abstract

Fingerprint

Dive into the research topics of 'Activity of recombinant human interleukin-21 (rIL-21) in patients (pts) with stage IV malignant melanoma (MM) without prior treatment: clinical data from a phase IIa study'. Together they form a unique fingerprint.

Medicine & Life Sciences